Penumbra (PEN) Cash from Investing Activities Growth (3y) (2017 - 2026)
Penumbra (PEN) Cash from Investing Activities Growth (3y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.63 Bn | 194.02 Bn | 7.27 Bn | 17.83% |
| 2 | Stryker | 127.42 Bn | 123.95 Bn | 4.50 Bn | -6.23% |
| 3 | Medtronic | 118.97 Bn | 109.75 Bn | 6.41 Bn | -24.52% |
| 4 | Boston Scientific | 73.39 Bn | 72.85 Bn | 3.85 Bn | -32.54% |
| 5 | Edwards Lifesciences | 51.97 Bn | 47.72 Bn | 1.35 Bn | -68.12% |
| 6 | Dexcom | 34.32 Bn | 32.37 Bn | 830.00 Mn | 37.39% |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | -11.04% |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | 19.58% |
| 9 | Steris | 23.04 Bn | 22.56 Bn | 684.20 Mn | -17.67% |
| 10 | Penumbra | 12.78 Bn | 12.12 Bn | 264.94 Mn | -139.02% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -139.02% |
| Mar 31, 2026 | -69.39% |
| Dec 31, 2025 | -204.16% |
| Sep 30, 2025 | -165.15% |
| Jun 30, 2025 | -40.17% |
| Mar 31, 2025 | -26.66% |
| Dec 31, 2024 | -101.50% |
| Sep 30, 2024 | 39.54% |
| Jun 30, 2024 | 9.38% |
| Mar 31, 2024 | 81.20% |
| Dec 31, 2023 | 63.55% |
| Sep 30, 2023 | 3.51% |
| Jun 30, 2023 | 50.36% |
| Mar 31, 2023 | 2.19% |
| Dec 31, 2022 | 30.01% |
| Sep 30, 2022 | -11.84% |
| Jun 30, 2022 | 49.88% |
| Mar 31, 2022 | -20.99% |
| Dec 31, 2021 | -28.85% |
| Sep 30, 2021 | -34.14% |